A new spectrum of skin toxic effects associated with the multikinase inhibitor vandetanib

Arch Dermatol. 2012 Dec;148(12):1418-20. doi: 10.1001/2013.jamadermatol.192.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Folliculitis / chemically induced
  • Hand-Foot Syndrome / etiology*
  • Humans
  • Hyperpigmentation / chemically induced
  • Male
  • Middle Aged
  • Photosensitivity Disorders / chemically induced
  • Piperidines / adverse effects*
  • Piperidines / therapeutic use
  • Protein Kinase Inhibitors / adverse effects*
  • Protein Kinase Inhibitors / therapeutic use
  • Quinazolines / adverse effects*
  • Quinazolines / therapeutic use
  • Thyroid Neoplasms / drug therapy*

Substances

  • Piperidines
  • Protein Kinase Inhibitors
  • Quinazolines
  • vandetanib